feed,title,long_url,short_url
Benzinga,"After FDA Approval For Ovarian Cancer Drug, ImmunoGen Becomes Top Pick For This Analyst",https://benzinga.com/general/biotech/22/11/29752739/after-fda-approval-for-ovarian-cancer-drug-immunogen-becomes-top-pick-for-this-analyst,https://bit.ly/3TJAzl0
Benzinga,A Look Into Chevron's Debt,https://benzinga.com/news/22/11/29753549/a-look-into-chevrons-debt,https://bit.ly/3TJAzS2
